Fredun Pharmaceuticals Limited at the Board of Directors meeting held on May 24, 2023, recommended final dividend at 7% per equity share having face value of INR 10 each for the financial year 2022-23; subject to the approval of the Shareholders at the upcoming Annual General Meeting of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
812.8 INR | +1.50% | +2.41% | -6.43% |
05-10 | Fredun Pharmaceuticals Limited Proposes Final Dividend for the Financial Year 2023-24 | CI |
05-08 | Fredun Pharmaceuticals' Net Profit Jumps in Fiscal Q4; Shares Dip 9% | MT |
1st Jan change | Capi. | |
---|---|---|
-6.43% | 45.74M | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
+11.88% | 216B | |
-0.78% | 219B | |
+5.90% | 164B |
- Stock Market
- Equities
- FREDUN6 Stock
- News Fredun Pharmaceuticals Limited
- Fredun Pharmaceuticals Limited Recommends Final Dividend for the Financial Year 2022-23